An engaging online program for life sciences professionals to learn, develop and refine their business development skills
Focusing on the areas of product valuation, negotiation, contracts and IP
Made up of 6 online courses, the Business Development Certification Series provides you with a platform for life sciences professionals to enhance their business development skills. Each course focuses on a specific, critical element of business development such as negotiation, product valuation or intellectual property.
In addition, you will learn from the past experiences of our expert faculty through case study examples of different deal situations. Combined, you will undertake an in-depth, wide-ranging, and varied learning experience, refining your skills in preparation for future partnering opportunities.
What will you learn?
Learn effective negotiation strategies and tactics to employ in future business negotiations including biopharma partnering deals
Master negotiation in a virtual setting with online group exercises
Review valuation methods, techniques and factors to ensure you are estimating both risk and return adequately
Gain a deep dive insight into the reasons why deals can fail or succeed through case study led sessions
Consider how your strategy for Intellectual Property (IP) can impact on partnering – pre and post finding a partner
Put yourself in an advantageous position by developing a strategic outreach plan
Online course structure
This 6-week program is built around EBD Group’s virtual BIO-Europe® 2020 event and is made up of multiple short online courses delivered in a variety of formats. Each course focuses on a specific topic within business development from negotiation and product valuation to IP and contracts.
As well as covering a range of business development topics the program also delivers content in a variety of formats.
Who is this course for?
This course is recommended for:
- Business development and licensing professionals
- Alliance management professionals
- R&D personnel who have significant interaction with business development
- Intellectual property personnel involved in the licensing process
- Biotech company CEOs
- Professionals who are new to business development and licensing or who have limited deal experience
The faculty is drawn from among the most experienced business development professionals in the biotech drug development industry as well as big pharma, many of whom have been instructors in other programs, and all of whom have extensive experience in the biotech industry.